BioAtla, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
BCAB on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
31 Mar 2026

Quick Takeaways

  • BCAB - BioAtla, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 544%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-431%</span>.
  • Most recent SEC facts end date: 31 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Return On Equity 543.8%, Return On Assets -179.9%, and Current Ratio 0.37x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

58.7/100

Caution Confidence low

Return On Equity

544%

Metric score 100.0/100

Return On Assets

-180%

Metric score 0.0/100

Financial Health

Current Ratio
0.37x

Strengths

Return On Equity and NetIncomeLoss YoY

Watchpoints

Return On Assets and Current Ratio

Key metrics snapshot

Return On Equity

544%

YoY: -431%

Industry median: -47% (n=218)

View history

Return On Assets

-180%

YoY: +122%

Industry median: -44% (n=217)

View history

Current Ratio

0.37x

YoY: -90%

Industry median: 3.67x (n=218)

View history

NetIncomeLoss YoY

15%

YoY:

Industry median: -12% (n=211)

View history

Profitability

Metric Latest value YoY change
Return On Equity 544% -431%
Return On Assets -180% +122%

Financial Health

Metric Latest value YoY change
Current Ratio 0.37x -90%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY 15%

Share Metrics

Metric Latest value YoY change
Common Stock, Shares, Outstanding 63,464,322 +9.2%
Common Stock, Value, Issued $6,000 0%
Weighted Average Number of Shares Outstanding, Basic 58,827,934 +21%
Weighted Average Number of Shares Outstanding, Diluted 58,827,934 +21%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $43,573,000 -31%
General and Administrative Expense $17,732,000 -19%
Operating Income (Loss) $59,305,000 +20%
Earnings Per Share, Basic -1.01 +30%
Earnings Per Share, Diluted -1.01 +30%
Cash and Cash Equivalents, at Carrying Value $7,118,000 -85%
Assets, Current $8,013,000 -84%
Property, Plant and Equipment, Net $120,000 -82%
Operating Lease, Right-of-Use Asset $5,532,000 +980%
Other Assets, Noncurrent $163,000
Assets $13,828,000 -74%
Accounts Payable, Current $8,194,000 +331%
Liabilities, Current $21,922,000 +51%
Operating Lease, Liability, Noncurrent $4,773,000
Liabilities $50,017,000 +31%
Retained Earnings (Accumulated Deficit) $545,646,000 -12%
Stockholders' Equity Attributable to Parent $36,189,000 -354%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $36,189,000 +154%
Liabilities and Equity $13,828,000 -74%
Share-based Payment Arrangement, Noncash Expense $5,434,000 -39%
Common Stock, Shares Authorized 350,000,000 0%
Common Stock, Shares, Issued 63,464,322 +9.2%
Common Stock, Par or Stated Value Per Share 0.0001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7,118,000 -85%
Deferred Tax Assets, Valuation Allowance $115,932,000 +13%
Deferred Tax Assets, Gross $117,094,000 +14%
Operating Lease, Liability $6,200,000 +642%
Lessee, Operating Lease, Liability, to be Paid $7,736,000 +816%
Property, Plant and Equipment, Gross $5,428,000 -29%
Operating Lease, Liability, Current $1,427,000 +71%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,528,000
Lessee, Operating Lease, Liability, to be Paid, Year One $1,484,000
Operating Lease, Weighted Average Discount Rate, Percent 0.09 +157%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,536,000 +16967%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,574,000 +86%
Deferred Tax Assets, Operating Loss Carryforwards $51,463,000 +52%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 200,000,000 0%
Unrecognized Tax Benefits $5,351,000 +17%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,621,000
Operating Lease, Payments $967,000 -43%
Additional Paid in Capital $509,451,000 +1.8%
Preferred Stock, Shares Outstanding 0
Deferred Tax Assets, Net of Valuation Allowance $1,162,000 +535%
Preferred Stock, Par or Stated Value Per Share 0.0001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY